D-0007-2015 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0007-2015 was initiated by Zydus Pharmaceuticals USA Inc on Aug 5, 2014 and is designated Class II. Reason for recall: Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance. The recall status is terminated (terminated Sep 22, 2017). Affected quantity: 5400 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 15, 2014
Initiation Date
Aug 5, 2014
Termination Date
Sep 22, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5400 bottles

Product description

ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA NDC 68382-022-01

Reason for recall

Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.

Distribution pattern

Nationwide

Code information

MP2292 Exp. 01/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0007-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0007-2015. Report a data issue: hello@regdatalab.com.